Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy

cryptocurrency 1 week ago
Flipboard
Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its respiratory vaccine …
Read Entire Article